The Role of Affinity Chromatography in Biologics Purification
The global Preparative and Process Chromatography market is a vital and rapidly evolving segment within the life sciences industry. Its core function is the large-scale separation, purification, and isolation of chemical compounds, which is absolutely critical for the manufacturing of pharmaceuticals, biopharmaceuticals, and high-purity chemicals. This market's robust expansion is primarily propelled by the increasing demand for life-saving biologics, particularly monoclonal antibodies and recombinant proteins like insulin, as well as a significant rise in chronic diseases such as diabetes, which necessitates mass production of these therapeutic agents.
While precise market valuations can vary, a general consensus points to a market size valued at approximately USD 6.94 billion in 2023, with a strong growth trajectory projected to reach around USD 11.85 billion by 2032. This impressive growth is supported by a solid Compound Annual Growth Rate (CAGR) of about 6.03% during the forecast period. The market's stability and growth are a direct reflection of its indispensable role in modern drug manufacturing, where the purity and safety of active pharmaceutical ingredients (APIs) are of paramount importance.
FAQs
What is affinity chromatography? Affinity chromatography is a powerful technique that uses a specific binding interaction between a target molecule and a ligand attached to a solid support to achieve highly selective purification.
How is it used for monoclonal antibodies? Affinity chromatography, particularly with Protein A ligands, is the industry standard for the initial capture and purification of monoclonal antibodies from cell culture media.